T cell responses during influenza infection: Getting and keeping control

Trends in Immunology

Volumn 32, Issue 5, 2011, Pages 225-231

  Kim, Taeg S ^a   Sun, Jie ^a   Braciale, Thomas J ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; HUMAN; INFLUENZA; LUNG INJURY; NONHUMAN; PANDEMIC; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS PNEUMONIA;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; HUMANS; INFLAMMATION; INFLUENZA A VIRUS; INFLUENZA, HUMAN; LUNG; LYMPHOCYTE ACTIVATION; MICE; T-LYMPHOCYTES;

EID: 79955609303     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2011.02.006     Document Type: Review

References (66)

1. Maines T.R., et al. Pathogenesis of emerging avian influenza viruses in mammals and the host innate immune response. Immunol. Rev. 2008, 225:68-84.
2. Peiris J.S., et al. Host response to influenza virus: protection versus immunopathology. Curr. Opin. Immunol. 2010, 22:475-481.
3. Rouse B.T., Sehrawat S. Immunity and immunopathology to viruses: what decides the outcome?. Nat. Rev. Immunol. 2010, 10:514-526.
4. Sanders C.J., et al. Respiratory epithelial cells in innate immunity to influenza virus infection. Cell Tissue Res. 2010, 343:13-21.
5. Holt P.G., et al. Regulation of immunological homeostasis in the respiratory tract. Nat. Rev. Immunol. 2008, 8:142-152.
6. Hammad H., Lambrecht B.N. Dendritic cells and epithelial cells: linking innate and adaptive immunity in asthma. Nat. Rev. Immunol. 2008, 8:193-204.
7. McGill J., et al. Innate immune control and regulation of influenza virus infections. J. Leukoc. Biol. 2009, 86:803-812.
8. Plantinga M., et al. Origin and functional specializations of DC subsets in the lung. Eur. J. Immunol. 2010, 40:2112-2118.
9. Strickland D.H., et al. Epithelial-dendritic cell interactions in allergic disorders. Curr. Opin. Immunol. 2010, 22:789-794.
10. Kim T.S., Braciale T.J. Respiratory dendritic cell subsets differ in their capacity to support the induction of virus-specific cytotoxic CD8+ T cell responses. PLoS ONE 2009, 4:e4204.
11. Sung S.S., et al. A major lung CD103 (alphaE)-beta7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 2006, 176:2161-2172.
12. Masten B.J., et al. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J. Immunol. 2006, 177:7784-7793.
13. Demedts I.K., et al. Identification and characterization of human pulmonary dendritic cells. Am. J. Respir. Cell Mol. Biol. 2005, 32:177-184.
14. del Rio M.L., et al. CD103- and CD103+ bronchial lymph node dendritic cells are specialized in presenting and cross-presenting innocuous antigen to CD4+ and CD8+ T cells. J. Immunol. 2007, 178:6861-6866.
15. Hao X., et al. Differential response of respiratory dendritic cell subsets to influenza virus infection. J. Virol. 2008, 82:4908-4919.
16. Manicassamy B., et al. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:11531-11536.
17. Belz G.T., et al. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:8670-8675.
18. Masson F., et al. Dendritic cells: driving the differentiation programme of T cells in viral infections. Immunol. Cell Biol. 2008, 86:333-342.
19. Lawrence C.W., Braciale T.J. Activation, differentiation, and migration of naive virus-specific CD8+ T cells during pulmonary influenza virus infection. J. Immunol. 2004, 173:1209-1218.
20. Bedoui S., Gebhardt T. Interaction between dendritic cells and T cells during peripheral virus infections: a role for antigen presentation beyond lymphoid organs?. Curr. Opin. Immunol. 2011, 23:124-130.
21. GeurtsvanKessel C.H., et al. Clearance of influenza virus from the lung depends on migratory langerin+CD11b- but not plasmacytoid dendritic cells. J. Exp. Med. 2008, 205:1621-1634.
22. Edelson B.T., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J. Exp. Med. 2010, 207:823-836.
23. Ballesteros-Tato A., et al. Temporal changes in dendritic cell subsets, cross-priming and costimulation via CD70 control CD8(+) T cell responses to influenza. Nat. Immunol. 2010, 11:216-224.
24. Kim T.S., et al. Antigen persistence and the control of local T cell memory by migrant respiratory dendritic cells after acute virus infection. J. Exp. Med. 2010, 207:1161-1172.
25. La Gruta N.L., et al. Primary CTL response magnitude in mice is determined by the extent of naive T cell recruitment and subsequent clonal expansion. J. Clin. Invest. 2010, 120:1885-1894.
26. Wolf A.I., et al. Plasmacytoid dendritic cells are dispensable during primary influenza virus infection. J. Immunol. 2009, 182:871-879.
27. Langlois R.A., Legge K.L. Plasmacytoid dendritic cells enhance mortality during lethal influenza infections by eliminating virus-specific CD8 T cells. J. Immunol. 2010, 184:4440-4446.
28. Lin K.L., et al. CCR2+ monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 2008, 180:2562-2572.
29. McGill J., et al. Protective influenza-specific CD8 T cell responses require interactions with dendritic cells in the lungs. J. Exp. Med. 2008, 205:1635-1646.
30. Tate M.D., et al. Neutrophils ameliorate lung injury and the development of severe disease during influenza infection. J. Immunol. 2009, 183:7441-7450.
31. Herold S., et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 2008, 205:3065-3077.
32. Aldridge J.R., et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:5306-5311.
33. Yoo J.K., et al. Identification of a novel antigen-presenting cell population modulating antiinfluenza type 2 immunity. J. Exp. Med. 2010, 207:1435-1451.
34. Hufford M.M., et al. Antiviral CD8+ T cell effector activities in situ are regulated by target cell type. J. Exp. Med. 2011, 208:167-180.
35. Topham D.J., et al. CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. J. Immunol. 1997, 159:5197-5200.
36. La Gruta N.L., et al. A question of self-preservation: immunopathology in influenza virus infection. Immunol. Cell Biol. 2007, 85:85-92.
37. Sun J., et al. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nat. Med. 2009, 15:277-284.
38. McGill J., et al. IL-15 trans-presentation by pulmonary dendritic cells promotes effector CD8 T cell survival during influenza virus infection. J. Exp. Med. 2010, 207:521-534.
39. Verbist K.C., et al. A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection. J. Immunol. 2011, 186:174-182.
40. Snell L.M., et al. CD8 T cell-intrinsic GITR is required for T cell clonal expansion and mouse survival following severe influenza infection. J. Immunol. 2010, 185:7223-7234.
41. Lin G.H., et al. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease. J. Immunol. 2009, 182:934-947.
42. Yu D., Vinuesa C.G. The elusive identity of T follicular helper cells. Trends Immunol. 2010, 31:377-383.
43. GeurtsvanKessel C.H., et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 2009, 206:2339-2349.
44. Moyron-Quiroz J.E., et al. Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity. Nat. Med. 2004, 10:927-934.
45. Choi Y.S., Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 2008, 205:3053-3064.
46. Graham M.B., et al. Influenza virus-specific CD4+ T helper type 2 T lymphocytes do not promote recovery from experimental virus infection. J. Exp. Med. 1994, 180:1273-1282.
47. Brown D.M., et al. CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch. J. Immunol. 2006, 177:2888-2898.
48. Debbabi H., et al. Primary type II alveolar epithelial cells present microbial antigens to antigen-specific CD4+ T cells. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L274-279.
49. Gereke M., et al. Alveolar type II epithelial cells present antigen to CD4(+) T cells and induce Foxp3(+) regulatory T cells. Am. J. Respir. Crit. Care Med. 2009, 179:344-355.
50. Crowe C.R., et al. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 2009, 183:5301-5310.
51. Humphreys I.R., et al. A critical role for OX40 in T cell-mediated immunopathology during lung viral infection. J. Exp. Med. 2003, 198:1237-1242.
52. Hussell T., et al. Co-stimulation: novel methods for preventing viral-induced lung inflammation. Trends Mol. Med. 2004, 10:379-386.
53. Humphreys I.R., et al. A critical role for ICOS co-stimulation in immune containment of pulmonary influenza virus infection. Eur. J. Immunol. 2006, 36:2928-2938.
54. Zhou J., et al. Cutting edge: engagement of NKG2A on CD8+ effector T cells limits immunopathology in influenza pneumonia. J. Immunol. 2008, 180:25-29.
55. Belkaid Y., Tarbell K. Regulatory T cells in the control of host-microorganism interactions (*). Annu. Rev. Immunol. 2009, 27:551-589.
56. Haeryfar S.M., et al. Regulatory T cells suppress CD8+ T cell responses induced by direct priming and cross-priming and moderate immunodominance disparities. J. Immunol. 2005, 174:3344-3351.
57. Antunes I., Kassiotis G. Suppression of innate immune pathology by regulatory T cells during influenza A virus infection of immunodeficient mice. J. Virol. 2010, 84:12564-12575.
58. Snelgrove R.J., et al. A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat. Immunol. 2008, 9:1074-1083.
59. Rygiel T.P., et al. Lack of CD200 enhances pathological T cell responses during influenza infection. J. Immunol. 2009, 183:1990-1996.
60. Couper K.N., et al. IL-10: The master regulator of immunity to infection. J. Immunol. 2008, 180:5771-5777.
61. Palmer E.M., et al. IFNgamma-producing, virus-specific CD8+ effector cells acquire the ability to produce IL-10 as a result of entry into the infected lung environment. Virology 2010, 404:225-230.
62. McKinstry K.K., et al. IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge. J. Immunol. 2009, 182:7353-7363.
63. Sun K., et al. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J. Virol. 2010, 84:5007-5014.
64. Carlson C.M., et al. Transforming growth factor-beta: activation by neuraminidase and role in highly pathogenic H5N1 influenza pathogenesis. PLoS Pathog. 2010, 6.
65. White M.R., et al. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am. J. Physiol. Lung Cell Mol. Physiol. 2005, 289:L606-616.
66. Snelgrove R.J., et al. An absence of reactive oxygen species improves the resolution of lung influenza infection. Eur. J. Immunol. 2006, 36:1364-1373.